Storbritannia -
engelsk -
MHRA (Medicines & Healthcare Products Regulatory Agency)
fragmin graduated syringe 10,000units/1ml solution for injection pre-filled syringes
pfizer ltd - dalteparin sodium - solution for injection - 10000unit/1ml
Belgia -
engelsk -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
fragmin 7500 iu (anti-xa)/0,75 ml inj. sol. s.c. pre-filled syr.
pfizer sa-nv - dalteparin sodium 7500 anti-xa u/0,75 ml - solution for injection - 7500 iu (anti-xa)/0,75 ml - dalteparin sodium 10000 iu/ml - dalteparin
Tyskland -
tysk -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fragmin
pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 50 milligramm
Tyskland -
tysk -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fragmin d
pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 50 milligramm
Tyskland -
tysk -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fragmin 10 ml multidose
pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 10000 i.e. anti-blutgerinnungsfaktor xa aktivität
Tyskland -
tysk -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fragmin 4 ml multidose
pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 25000 i.e. anti-blutgerinnungsfaktor xa aktivität
Tyskland -
tysk -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
fragmin p
pfizer pharma gmbh (8075658) - dalteparin-natrium ((mw: ca. 6000)) - injektionslösung - teil 1 - injektionslösung; dalteparin-natrium ((mw: ca. 6000)) (26756) 2500 i.e. anti-blutgerinnungsfaktor xa aktivität
New Zealand -
engelsk -
Medsafe (Medicines Safety Authority)
fragmin
pfizer new zealand limited - dalteparin sodium 25000 iu/ml - solution for injection - 25000 iu/ml - active: dalteparin sodium 25000 iu/ml excipient: water for injection - · for the prevention of clotting in the extracorporeal system during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency
Israel -
engelsk -
Ministry of Health
fragmin 25000 iuml
pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 5000 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism.unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.
Israel -
engelsk -
Ministry of Health
fragmin 2500 i.u 0.2 ml
pfizer pfe pharmaceuticals israel ltd - dalteparin sodium - solution for injection - dalteparin sodium 2500 iu / 0.2 ml - dalteparin - dalteparin - prevention of clotting during haemodialysis and haemofiltration in connection with acute renal failure or chronic renal insufficiency. treatment of acute deep venous thrombosis and/or pulmonary embolism. unstable coronary artery disease. thromboprophylaxis in conjunction with surgery. prophylaxis in patients with substantially increased risk for venous thromboembolism and that are temporarily immobilized due to acute illness such as cardiac insufficiency respiratory insufficiency and severe infections.cancer patients : treatment and secondary prevention of deep-vein thrombosis and/or pulmonary embolism.